德国多中心,观察者盲,随机和主动控制平行组试验的研究方案,将维持电治疗与常规治疗进行比较,以预防克洛扎耐药精神分裂症的复发
Anton Deicher1, Sebastian Karl1, Marie-Luise Otte2,3
1Department of Psychiatry and Psychotherapy, Research Group Brain Stimulation, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, J5, 68159, Mannheim, Germany.
BMC psychiatry
|May 26, 2025
概括
这项研究调查了维持电疗法 (mECT) 是否可以预防克洛扎耐药精神分裂症 (CRS) 复发. 这些发现可能会显著改变严重精神疾病的治疗指南.
科学领域:
- 精神病学是一个精神病学.
- 临床神经科学 临床神经科学
- 翻译医学是一种翻译医学.
背景情况:
- 精神分裂症是一种严重,昂贵的精神障碍,治疗选择有限.
- 15-30%的患者对抗精神病药物有抗药性,甚至是克洛扎宾.
- 电疗法 (ECT) 对克洛扎耐药精神分裂症 (CRS) 有效,但复发率很高.
研究的目的:
- 测试维持电疗法 (mECT) 加上常规治疗 (TAU) 是否可以预防CRS患者的复发.
- 为了比较mECT + TAU与TAU单独用于复发预防.
- 评估mECT对CRS中复发率和患者结局的影响.
主要方法:
- 一个多中心,随机,观察者盲目,主动控制的试验 (MECT-RESIST).
- 84名患者 (18-65岁) 诊断出CRS和高BPRS得分,对初始ECT有反应.
- 随机分配到mECT + TAU或单独TAU28周,随后进行12个月的随访.
主要成果:
- 主要终点:复发的时间.
- 二级终点:没有复发的比例,功能,生活质量,抑郁症状,整体精神分裂症症状,,压力,自我污名化和认知.
- 数据收集和分析将在2025年至2028年之间进行.
结论:
- 这项试验将检查CRS患者的mECT有效性,这些患者在初始ECT后得到改善.
- 如果mECT显示出优异的复发预防,它可能会显著影响CRS治疗策略.
- 结果可能会导致修订治疗指南,挑战ECT目前的"最后比例"地位.
相关概念视频
01:30Electroconvulsive Therapy
206
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
206
01:26Psychosis: Goals of Pharmacotherapy
217
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
217
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
01:28Drug Therapy
107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
107
01:16Crossover Experiments
3.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
3.7K